Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Tinglizi
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Compound Tinglizi is a formulation used in Traditional Chinese Medicine, primarily containing Lepidium seed (葶苈子) as its main ingredient. It is used to treat conditions like pulmonary heart disease and heart failure. The formulation is designed to enhance the therapeutic effects of Lepidium seed, which is known for its properties in draining excess water and phlegm from the lungs, thus alleviating symptoms such as wheezing and edema.
- Other names
- 复方葶苈子胶囊
02
Targets
HMOX1 (Heme oxygenase 1)IL-6 (Interleukin 6)TP53 (Cellular Tumor Antigen p53 R175H)
Beyond the preview
Go deeper on Compound Tinglizi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Tinglizi.